Stifel analyst Justin Keywood lowered the firm’s price target on Andlauer Healthcare to C$55 from C$60 and keeps a Buy rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ANDHF:
- Andlauer Healthcare price target lowered to C$43 from C$44 at Scotiabank
- Andlauer Healthcare upgraded to Outperformer on Friday at CIBC
- Andlauer Healthcare upgraded to Outperformer from Neutral at CIBC
- Zillow Group Reports Third-Quarter 2023 Financial Results
- Andlauer Healthcare price target lowered to C$44 from C$48 at Scotiabank